Warburg Pincus has appointed Francesco Granata as an ‘executive-in-residence’, whilst Montagu Private Equity has hired Martin McCourt, the former chief executive of Dyson, as a director.
The appointments are part of a wider trend within private equity which has seen a shift towards operational improvement as a means to create value within a portfolio. As such, some firms have aggressively built in-house operational expertise.
Granata will work within Warburg Pincus’ healthcare sector team, helping to identify and evaluate new investments in the biopharmaceutical sector, the firm said in a statement. Based in London, he will focus in particular on Europe, but will provide strategic counsel across the group’s global healthcare portfolio, the firm said.
He has more than 35 years’ experience in the pharmaceutical and biotechnology industries. Most recently, he was an executive vice president at NASDAQ-listed biotech company Biogen Idec, where he led the company’s global commercial operations.
Montagu meanwhile has appointed Martin McCourt, former chief executive of Dyson Group, as a director.
He will work with Montagu portfolio company management teams to help develop and grow their businesses, and will also assist with new investment opportunities, the firm said.
McCourt has worked for more than 35 years in manufacturing, design, and marketing roles at companies including Mars, Duracell, Toshiba and Pelikan. He spent 15 years at Dyson Group, known principally for its vacuum cleaners. At Dyson, he helped to increase profits tenfold, and aided its transformation from a UK-focused business to one with a global footprint.